|
|||||
       |
(Photos8.com) The number of hospital admissions for Americans age 45 and older from medication and drug-related conditions doubled between 1997 and 2008, according to a report released today by the Agency for Healthcare Research and Quality (AHRQ), in the U.S. Department of Health and Human Services. AHRQ defines medication and drug-related conditions to . . . → Read More: Drug-Related Hospitalizations Double for Age 45+ (Agricultural Research Service, USDA) University of Maryland in College Park has received a $5 million grant from National Science Foundation to lead a multi-institutional research partnership to help develop crop plants able to withstand drought conditions. The project will focus on guard cells in the canola plant (Brassica napus) — pictured right. Canola . . . → Read More: NSF Grant Funds Research on Drought-Resistant Crops Pacific yew tree (National Cancer Institute) A research team from University of Edinburgh in Scotland and Unwha Biotech, a company in Jeonju Si, Korea, has found a way of using stem cells from tree bark that could lead to a simpler and lower-cost process for making the cancer drug paclitaxel. The drug is . . . → Read More: Plant Stem Cells Point to Cheaper Cancer Drug  One comment - (Comments are closed)  Joint ventures/collaborations  biotechnology, stem cells, university (Photos8.com) In the third quarter of 2010, venture capital (VC) investors put $5.5 billion into 662 deals for U.S.-based companies, down 5 percent in dollars invested but a 2 percent increase in deals from the same period last year, according to Dow Jones VentureSource. Science-based companies were among those experiencing a downturn in . . . → Read More: Venture Investing Down in Q3, Up for Year-to-Date National Mall, Washington, D.C. Brain model Ben Franklin is in the house Space Cadet Rubik's Cube Blowing bubbles More photos on Flickr. All photos by Alan Kotok . . . → Read More: Scenes from today’s USA Science and Engineering Festival UTHealth's Bruce Butler (left) and BioHouston's Jacqueline Northcut sign the new collaborative agreement between their organizations (University of Texas Health Science Center at Houston) Two business incubators in Houston, Texas aimed at biomedical start up companies, have agreed to collaborate and share facilities. The University of Texas Health Science Center at Houston (UTHealth) . . . → Read More: Houston Biomed Incubators to Collaborate, Combine Labs (Agricultural Research Service/USDA) Scientists from the USDA’s Agricultural Research Service (ARS) are developing vaccines to help protect against common diseases faced by healthy farm-raised catfish. Biologists and aqua pathologists from ARS labs in Auburn, Alabama and Chestertown, Maryland are focusing on protections for catfish against against the bacteria Streptococcus (S.) iniae, S. agalactiae, . . . → Read More: New Vaccines Developed for Farm-Raised Catfish (SunLadder/Wikimedia Commons) Researchers from Empa, the Swiss Federal Laboratories for Materials Testing and Research in Duebendorf, studied the full lifetime of four lighting technologies, and found compact fluorescent lighting (CFL) to inflict the least environmental damage. The analysis includes consideration of CFL’s mercury content, since exposure to elemental mercury when absorbed through the . . . → Read More: Life-Cycle Analysis Shows CFL Bulbs Most Enviro Friendly Prof. Cross in front of the 900-megahertz magnet. (Florida State University) Using powerful magnets [sponsored link] to scan proteins’ atomic structures, scientists at Florida State University (FSU) in Tallahassee and Brigham Young University in Provo, Utah are close to understanding why some drugs to treat the influenza A virus have become less effective, . . . → Read More: Magnets Improve Understanding of Influenza Drugs One comment - (Comments are closed) Intellectual property, Joint ventures/collaborations biomedical, patent, pharmaceuticals, physical sciences, university Color-enhanced staphylococcus bacteria (NIH) Morphotek Inc., a developer of protein and antibody products in Exton, Pennsylvania, said it received a $2.5 million contract from the U.S. Department of Defense (DoD) to fund further development of the company’s monoclonal antibody therapies against disease-causing staphylococcal strains and toxins. In February 2008, Morphotek received funding to . . . → Read More: DoD Awards Contract for Bioweapon Therapies |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts
You must be logged in to post a comment.